Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?

HIGHLIGHTS: Imaging of the dopamine transporter (DAT) (in particular using 11C- or 18F-PE2I) most reliably and precisely measures neurodegeneration of the dopaminergic system in parkinsonian disorders and its progression in longitudinal studies. Combining DAT imaging and iron- and neuromelanin-sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Prange, Stéphane, Theis, Hendrik, Banwinkler, Magdalena, van Eimeren, Thilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496752/
https://www.ncbi.nlm.nih.gov/pubmed/36138882
http://dx.doi.org/10.3390/brainsci12091146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496752/
https://www.ncbi.nlm.nih.gov/pubmed/36138882
http://dx.doi.org/10.3390/brainsci12091146

Ejemplares similares